The AstraZeneca PLC ADR
slumped 0.87% to $49.97 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average
rising 0.20% to 31,437.80 and the NASDAQ Composite Index
falling 0.25% to 13,972.53. The ADR’s fall snapped a two-day winning streak. AstraZeneca PLC ADR closed $14.97 short of its 52-week high ($64.94), which the company achieved on July 20th.
The ADR demonstrated a mixed performance when compared to some of its competitors Wednesday, as AbbVie Inc.
fell 1.28% to $104.05, Amgen Inc.
rose 0.76% to $238.46, and Gilead Sciences Inc.
fell 0.01% to $67.29. Trading volume (9.6 M) remained 2.8 million below its 50-day average volume of 12.4 M.